Insmed (INSM) FCF Margin Growth (3y) (2021 - 2026)
Insmed (INSM) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Insmed | 22.60 Bn | 21.38 Bn | 258.54 Mn | 15,562.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,562.00 |
| Dec 31, 2025 | 7,033.00 |
| Sep 30, 2025 | 698.00 |
| Jun 30, 2025 | -3,332.00 |
| Mar 31, 2025 | -9,198.00 |
| Dec 31, 2024 | -256.00 |
| Sep 30, 2024 | -3,991.00 |
| Jun 30, 2024 | 1,400.00 |
| Mar 31, 2024 | 12,475.00 |
| Dec 31, 2023 | 591.00 |
| Sep 30, 2023 | -3,912.00 |
| Jun 30, 2023 | -7,569.00 |
| Mar 31, 2023 | -6,812.00 |
| Dec 31, 2022 | -1,250.00 |
| Sep 30, 2022 | -211.00 |
| Jun 30, 2022 | 12,254.00 |
| Mar 31, 2022 | 16,811.00 |
| Dec 31, 2021 | 66,402.00 |